These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2427283)

  • 21. Comparative study of needle biopsy and alpha-foetoprotein detection in the diagnosis of primary hepatocellular carcinoma.
    Deshpande AD; Patil SD; Talib SH
    J Assoc Physicians India; 1981 Feb; 29(2):129-32. PubMed ID: 6167562
    [No Abstract]   [Full Text] [Related]  

  • 22. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
    Ballesta AM; Calvet X; Filella X; Bruix J; Bru C; Molina R; Rodes J
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):39-41. PubMed ID: 2480420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the correlation between histological findings and results of liver function tests: from the pathological standpoint (author's transl)].
    Yamamoto H
    Rinsho Byori; 1979; 27(1):31-4. PubMed ID: 85729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins].
    Aoyagi Y; Ichida F
    Rinsho Byori; 1983 Dec; 31(12):1286-93. PubMed ID: 6202901
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma.
    Suzuki Y; Aoyagi Y; Mori S; Suda T; Naitoh A; Isokawa O; Yanagi M; Igarashi H; Asakura H
    J Gastroenterol Hepatol; 1996 Apr; 11(4):358-65. PubMed ID: 8713703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of primary hepatocellular carcinoma in early stage: report of 134 cases.
    Chin Med J (Engl); 1979 Nov; 92(11):801-6. PubMed ID: 92394
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum AFP subfractions in patients with hepatic cancer or germ cell tumor of the gonads].
    Ishiguro T; Fukui M; Sugitachi I; Sakaguchi H; Itani S
    Gan No Rinsho; 1985 May; 31(6 Suppl):611-5. PubMed ID: 2411963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis.
    Tsuchida Y; Kaneko M; Fukui M; Sakaguchi H; Ishiguro T
    J Pediatr Surg; 1989 Apr; 24(4):350-5. PubMed ID: 2471822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the diagnostic value of alpha-1-fetoprotein (AFP) in hepatocellular carcinoma.
    Zeana C; Macarie C
    Acta Med Pol; 1976; 17(2):159-3. PubMed ID: 59516
    [No Abstract]   [Full Text] [Related]  

  • 32. Small hepatocellular carcinoma: clinical analysis of 30 cases.
    Zhaoyou T; Yeqin Y; Zhiying L; Xinda Z; Binghui Y; Yunzhen C; Jizhen L; Chenlong T
    Chin Med J (Engl); 1979 Jul; 92(7):455-62. PubMed ID: 90587
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 34. Things are seldom what they seem.
    Thibault GE
    N Engl J Med; 1992 Dec; 327(23):1663-6. PubMed ID: 1279423
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
    Aoyagi Y; Isemura M; Suzuki Y; Sekine C; Soga K; Ozaki T; Ichida F
    Lancet; 1985 Dec; 2(8468):1353-4. PubMed ID: 2415789
    [No Abstract]   [Full Text] [Related]  

  • 37. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
    Shen W; Shen DM
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 39. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early diagnosis of hepatocellular carcinoma.
    Okazaki N; Yoshino M; Yoshida T; Takayasu K; Moriyama N; Makuuchi M; Yamazaki S; Hasegawa H; Noguchi M; Hirohashi S
    Hepatogastroenterology; 1990 Oct; 37(5):480-3. PubMed ID: 1701411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.